Funding event
The round itself, as filedInferred stagePre-seed
Sold of offered$991K of Indefinite
Filed2026-08-14
Days since filing51
- Exemption claimed
- Rule 506(b)
- First-ever Form D
- Yes
- Date of first sale
- 2026-05-15
Investors
No investors named: Form D does not list them
Officers on the filing
Names and roles as filed; addresses are never stored- CARLOS A DOMINGUEZExecutive Officer · Director
- JOSE F RODRIGUEZ-ORENGOExecutive Officer · Director
- SURANGANIE DHARMAWARDHANEExecutive Officer
- ARTURO GONZALEZDirector
- NEIL SANKARExecutive Officer
Health flags
Three flags, each with the raw inputs behind it · as of 2026-10-03UndersubscribedNot flagged—4.6 months since first sale
Prior raiseNot flagged$500K prior raiseprior filing 2026-08-14
AmendedNot flaggedNo amendmentNo D/A on file
Open roles
On the employer's own careers page · checked 2026-09-240
Pre-posting windowNot enough dataShown once this sector and stage have 20 observed lags from filing to first posting.
No open roles foundWe read careers pages daily.
All filings
Every filing for this company, newest first, amendments includedAlso raised in Health & bio
Same sector, 28 days to 2026-10-04Altay TherapeuticsSeries A · $15.7M of $45.1M · San Carlos, CAQuietCarebilitySeries A · $8.8M of $8.8M · Richardson, TXQuiet
75 rounds in Health & bio in the 28 days to 2026-10-03, against 71 in the 28 days before.